The next leap in oncology therapeutics demands speed, precision, and rapid molecular innovation — and AI-driven antibody design (AIDD) is beginning to deliver. In this talk, we will unveil how our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback